Academic Journal

Cancer Therapy-Induced Encephalitis

التفاصيل البيبلوغرافية
العنوان: Cancer Therapy-Induced Encephalitis
المؤلفون: Nicolas P. Desbaillets, Andreas F. Hottinger
المصدر: Cancers ; Volume 16 ; Issue 21 ; Pages: 3571
بيانات النشر: Multidisciplinary Digital Publishing Institute
سنة النشر: 2024
المجموعة: MDPI Open Access Publishing
مصطلحات موضوعية: cancer, adverse event, neurotoxicity, encephalitis, autoimmune, immunotherapy, checkpoint inhibitor, CAR-T, ICANS, BiTE
الوصف: Encephalitis associated with cancer therapies is a rare but serious complication that can significantly impact patients’ quality of life and it requires prompt identification and management. Over the past two decades, immunotherapy—particularly immune checkpoint inhibitors—has become a cornerstone of cancer treatment, with up to half of metastatic cancer patients in economically developed countries now receiving these therapies. The widespread adoption of immunotherapy has led to improved survival rates and long-term remissions, even in patients with advanced metastatic disease. However, as immune modulators, these therapies can trigger a range of immune-related adverse events, including a variety of novel neurological toxicities. Among these, encephalitis is of particular concern due to its potential severity, which can compromise treatment outcomes. This review aims to provide a comprehensive overview of the literature on this condition, highlighting optimal diagnostic strategies and management approaches to mitigate the risk of significant morbidity, while also comparing encephalitis induced by immunotherapy with that caused by traditional chemotherapies and targeted oncologic treatments.
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: English
Relation: Cancer Immunology and Immunotherapy; https://dx.doi.org/10.3390/cancers16213571
DOI: 10.3390/cancers16213571
الاتاحة: https://doi.org/10.3390/cancers16213571
Rights: https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.9CAFC909
قاعدة البيانات: BASE